Commentary

Debating the clinical trial upending colonoscopy practices


 

Final take-home messages

Dr. Wilson: Dr. Lin, I’ll turn the last word over to you, as the person who is probably discussing the choice of screening modalities more than any of us, before someone would get referred to someone like Dr. Johnson. What’s your final take-home message about the NEJM study and the state of colon cancer screening in the United States?

Dr. Lin: My take-home points about the study are that there were some limitations, but it is good to finally have a randomized trial of colonoscopy screening 2 decades after we really started doing that in the United States. It won’t immediately change – nor do I think it should – the way we practice and discuss different options. I think that some of Dr. Johnson’s points about making sure that whoever’s doing the colonoscopies for your practices is doing it in a high-quality way are really important. Just as it’s important, if you’re doing the fecal tests, to make sure that all patients who have positives get expeditiously referred for colonoscopy.

Dr. Johnson: Perry, I’d like to make one concluding comment as the gastroenterology expert in this discussion. I’ve had countless questions about this study from my patients and my peers. I tell them the following: Don’t let the headlines mislead you.

When you look at this study, the instrument is not so much the question. We know that getting the test is the first step in colon cancer screening. But we also know that getting the test done, with the highest-quality providers and the best-quality performance, is really the key to optimizing the true value of colonoscopy for colon cancer prevention.

So please don’t lose sight of this when reading the headlines in the media around this study. We really need to analyze the true characteristics of what we call a quality performance, because that’s what drives success and that’s what prevents colon cancer.

Dr. Wilson: Dr. Johnson and Dr. Lin, thank you very much. I appreciate you spending time with me here today and wish you all the best.

I guess I’ll sum up by saying that if you’re getting a colonoscopy, make sure it’s a good one. But do get screened.

This video originally appeared on WebMD. A transcript appeared on Medscape.com.

Pages

Recommended Reading

Personalized breast screening a step closer to reality
MDedge Hematology and Oncology
The right indoor relative humidity could ward off COVID
MDedge Hematology and Oncology
More vaccinated people dying of COVID as fewer get booster shots
MDedge Hematology and Oncology
Not all plant-based diets equal for CRC risk reduction
MDedge Hematology and Oncology
Less than a third of Americans aware of cancer risk from alcohol
MDedge Hematology and Oncology
Diagnosed too late
MDedge Hematology and Oncology
New melting hydrogel bandage could treat burn wounds faster, with less pain
MDedge Hematology and Oncology
New test that detects 14 cancers focuses on sugars, not DNA
MDedge Hematology and Oncology
Multiple myeloma diagnosed more via emergency care during COVID
MDedge Hematology and Oncology
COVID booster shot poll: People ‘don’t think they need one’
MDedge Hematology and Oncology